Round 3 of the IB Catalyst was launched on 11 December 2014. The catalyst provides funding for industry and academia, preferably in collaboration together, across five ‘streams’ covering early-, mid- and late-stage research.
The round 3 call for feasibility studies is still open, which includes early-stage feasibility work and late-stage pre-experimental feasibility work.
Interested applicants must register their interest by 13 May and the deadline for applications is 20 May.
N.b. The IB Catalyst remit includes bioprocessing for biopharmaceutical products. This remains a major opportunity for the pharma and IB sector. Follow the link for further details, or contact the IB Catalyst Coordinator Adrian Higson.